Mapping vascular network architecture in primate brain using ferumoxytol-weighted laminar MRI

  1. Laboratory for Brain Connectomics Imaging, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan
  2. Siemens Healthcare K.K., Tokyo, Japan
  3. Department of Radiology, Washington University Medical School, St. Louis, United States
  4. Department of Neuroscience, Washington University Medical School, St. Louis, United States

Peer review process

Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the editors and peer reviewers.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Shella Keilholz
    Emory University and Georgia Institute of Technology, Atlanta, United States of America
  • Senior Editor
    Andre Marquand
    Radboud University Nijmegen, Nijmegen, Netherlands

Reviewer #1 (Public review):

Summary:

Audio et al. measured cerebral blood volume (CBV) across cortical areas and layers using high-resolution MRI with contrast agents in non-human primates. While the non-invasive CBV MRI methodology is often used to enhance fMRI sensitivity in NHPs, its application for baseline CBV measurement is rare due to the complexities of susceptibility contrast mechanisms. The authors determined the number of large vessels and the areal and laminar variations of CBV in NHP, and compared those with various other metrics.

Strengths:

Noninvasive mapping of relative cerebral blood volume is novel for non-human primates. A key finding was the observation of variations in CBV across regions; primary sensory cortices had high CBV, whereas other higher areas had low CBV. The measured CBV values correlated with previously reported neuronal and receptor densities.

Weaknesses:

A weakness of this manuscript is that the quantification of CBV with postprocessing approaches to remove susceptibility effects from pial and penetrating vessels is not fully validated, especially on a laminar scale. Further specific comments follow.

(1) Baseline CBV indices were determined using contrast agent-enhanced MRI (deltaR2*). Although this approach is suitable for areal comparisons, its application at a laminar scale poses challenges due to significant contributions from large vessels including pial vessels. The primary concern is whether large-vessel contributions can be removed from the measured deltaR2* through processing techniques.

(2) High-resolution MRI with a critical sampling frequency estimated from previous studies (Weber 2008, Zheng 1991) was performed to separate penetrating vessels. However, this approach is still insufficient to accurately identify the number of vessels due to the blooming effects of susceptibility and insufficient spatial resolution. The reported number of penetrating vessels is only applicable to the experimental and processing conditions used in this study, which cannot be generalized.

(3) Baseline R2* is sensitive to baseline R2, vascular volume, iron content, and susceptibility gradients. Additionally, it is sensitive to imaging parameters; higher spatial resolution tends to result in lower R2* values (closer to the R2 value). Thus, it is difficult to correlate baseline R2* with physiological parameters.

(4) CBV-weighted deltaR2* is correlated with various other metrics (cytoarchitectural parcellation, myelin/receptor density, cortical thickness, CO, cell-type specificity, etc.). While testing the correlation between deltaR2* and these other metrics may be acceptable as an exploratory analysis, it is challenging for readers to discern a causal relationship between them. A critical question is whether CBV-weighted deltaR2* can provide insights into other metrics in diseased or abnormal brain states.

Reviewer #2 (Public review):

Summary:

This manuscript presents a new approach for non-invasive, MRI-based, measurements of cerebral blood volume (CBV). Here, the authors use ferumoxytol, a high-contrast agent and apply specific sequences to infer CBV. The authors then move to statistically compare measured regional CBV with known distribution of different types of neurons, markers of metabolic load and others. While the presented methodology captures and estimated 30% of the vasculature, the authors corroborated previous findings regarding lack of vascular compartmentalization around functional neuronal units in the primary visual cortex.

Strengths:

Non invasive methodology geared to map vascular properties in vivo.

Implementation of a highly sensitive approach for measuring blood volume.

Ability to map vascular structural and functional vascular metrics to other types of published data.

Weaknesses:

The key issue here is the underlying assumption about the appropriate spatial sampling frequency needed to captures the architecture of the brain vasculature. Namely, ~7 penetrating vessels / mm2 as derived from Weber et al 2008 (Cer Cor). The cited work, begins by characterizing the spacing of penetrating arteries and ascending veins using vascular cast of 7 monkeys (Macaca mulatta, same as in the current paper). The ~7 penetrating vessels / mm2 is computed by dividing the total number of identified vessels by the area imaged. The problem here is that all measurements were made in a "non-volumetric" manner and only in V1. Extrapolating from here to the entire brain seems like an over-assumption, particularly given the region-dependent heterogeneity that the current paper reports.

Comments on revisions:

I appreciate the effort made to improve the manuscript. That said, the direct validation of the underlying assumption about spatial resolution sampling remains unaddressed in the final version of this manuscript. With the only intention to further strengthen the methodology presented here, I would encourage again the authors to seek a direct validation of this assumption for other brain areas.

In their reply, the authors stated "... line scanning or single-plane sequences, at least on first impression, seem inadequate for whole-brain coverage and cortical surface mapping. ". This seems to emanate for a misunderstanding as the method could be used to validate the mapping, not to map per-se.

Author response:

The following is the authors’ response to the original reviews.

Public Reviews:

Reviewer #1 (Public review):

Summary:

Audio et al. measured cerebral blood volume (CBV) across cortical areas and layers using high-resolution MRI with contrast agents in non-human primates. While the non-invasive CBV MRI methodology is often used to enhance fMRI sensitivity in NHPs, its application for baseline CBV measurement is rare due to the complexities of susceptibility contrast mechanisms. The authors determined the number of large vessels and the areal and laminar variations of CBV in NHP and compared those with various other metrics.

Strengths:

Non-invasive mapping of relative cerebral blood volume is novel for non-human primates. A key finding was the observation of variations in CBV across regions; primary sensory cortices had high CBV, whereas other higher areas had low CBV. The measured CBV values correlated with previously reported neuronal and receptor densities.

Weaknesses:

A weakness of this manuscript is that the quantification of CBV with postprocessing approaches to remove susceptibility effects from pial and penetrating vessels, as well as orientation dependency, is not fully validated, especially on a laminar scale. Further specific comments follow.

We suspect that the comment regarding the lack of validation on laminar level stems from an error made by the corresponding author in the original bioRxiv submission (v1, May 17th https://www.biorxiv.org/content/10.1101/2024.05.16.594068v1?versioned=true), where Figure 3 which contains laminar validation was lost during pdf conversion. After submitting to E-Life, this mistake was quickly identified, and a corrected manuscript was re-uploaded to the bioRxiv (v2, June 5th, https://doi.org/10.1101/2024.05.16.594068). Although we informed the eLife staff about the update, it appears that the revised manuscript may not have reached reviewer #1 in time. We sincerely apologize for any confusion or inconvenience this may have caused.

(1) Baseline CBV indices were determined using contrast agent-enhanced MRI (deltaR2*). Although this approach is suitable for areal comparisons, its application on a laminar scale has not been validated in the literature or in this study. By comparing with histological vascular information of V1, the authors attempted to validate their approach. However, the generalization of their method is questionable. The main issue is whether the large vessel contribution is minimized by processing approaches properly in various cortical areas (such as clusters 1-3 in Figure 5). It would be beneficial to compare deltaR2* with deltaR2 induced by contrast agents in a few selected slices, as deltaR2 is supposed to be sensitive to microvessels, not macrovessels. Please discuss this issue.

The requested validation is presented in Figure 3F, which compares our deltaR2* measurements with previously invasive estimates of large vessel, capillary and cytochrome oxidase (CO) levels in V1 (Weber et al., 2008; doi.org/10.1093/cercor/bhm259). Our deltaR2* values show a stronger correspondence with microvascularity and CO levels than large vessels. Moreover, Figure 3D illustrates relative differences between V1 and V2, which closely align with the relative vascular volume differences reported by Zheng et al., 1991. It is important to note that Weber and colleagues averaged across V2-V5 due to similar vascularity across these areas. In our material, we also observed similar vascularity in these areas, though V5 (e.g., MT) has slightly denser vascularity, in agreement with reports of CO staining.

Additionally, we report similar GM/WM vascular density, and high vascular density in primary sensory areas. Unfortunately, available ground-truth data on vascularity does not provide further (general) validation data for laminar vasculature in macaques (such as those in cluster 1-3; Fig. 5). That said, we have provided substantial evidence linking whole-brain vascular measures with variations in neuron (for data distribution, see Supp. Fig. 6F) and receptor densities, which we believe provides strong support for our approach.

We would like to clarify that the authors do not assert that gradient-echo MRI is exclusively sensitive to microvessels and not macrovessels. This is not stated anywhere in the manuscript. If any sentence appears misleading, please let us know, and we will consider revising it. It is well-established that large vessels contribute to ΔR2* (Ogawa et al., 1993; Boxerman et al., 1995), and this is clearly stated in the manuscript (introduction, methods, results and discussion) and demonstrated in Figures 2A, B, and Supp. Figs. 2, 3, and 4. The primary concern, as the reviewer also noted, is whether we have sufficiently minimized the contribution of large vessels in our parcellated data analysis.

At the parcellated level, we used the median value to avoid skewness in the data distribution, which primarily arises from large vessels, as regions near these vessels exhibit higher ΔR2*. The skewness of ΔR2* is also visible in Figure 1F, G. While this approach mitigates this large-small vessel issue, it does not entirely resolve it, as a slight linear increase toward the cortical surface remains (in all parcels). This is likely due to our inability to delineate all penetrating vessels as shown in Figure 2E and because contrast agents cumulatively accumulate toward superficial layers where blood originates and returns to the pial surface. To mitigate this issue, we detrended across layers the parcellated profiles, obtaining results similar to the ground-truth measures of vascularity in V1-V5 and CO histology in V1.

(2) High-resolution MRI with a critical sampling frequency estimated from previous studies (Weber 2008, Zheng 1991) was performed to separate penetrating vessels, which is considered one of the major advancements in this study. However, this approach is still insufficient to accurately identify the number of vessels due to the blooming effects of susceptibility and insufficient spatial resolution. There was no detailed description of the detection criteria. More importantly, the number of observable penetrating vessels is dependent on imaging parameters and the dose of the contrast agent. If imaging slices were obtained in parallel to the cortex with higher in-plane resolution, it would likely improve the detection of penetrating vessels. Using higher-field MRI would further enhance the detection of penetrating vessels. Therefore, the reported value is only applicable to the experimental and processing conditions used in this study. Detailed selection criteria should be mentioned, and all potential pitfalls should be discussed.

We believe that Figure 2 represents a significant conceptual and data analysis advancement in the field of vascular imaging. To the best of our knowledge, this is the first MRI study attempting to assess vessel density across cortical layers and compare the number of vessels to the known ground-truth. While we do not claim to have achieved a perfect solution (as shown in Figure 2), we offer a robust challenge to the imaging community by introducing this novel benchmarking approach. Our hope is that this conceptual framework will inspire the MR imaging community to tackle this challenge.

Regarding imaging parameters, TE did not have much effect on our results, with a slight effect observed in the superficial layers due to the presence of large pial vessels (blooming effect; Fig. 2C). This also suggests that similar results could be achieved by changing the contrast agent dose, though there are, of course, CNR requirements and limitations at either end of the spectrum.

We completely agree with the reviewer that spatial resolution is critical in resolving the arterio-venous networks, and we have dedicated significant attention to this topic in the introduction, results and discussion sections. We also agree with the reviewer that if imaging slices were obtained in parallel to the cortex with higher in-plane resolution, it would improve the detection of vessels. However, while this approach is ideal for counting vessels in a single plane and isolated region of cortex, it is less suited to the surface mapping of vessels, which is the focus of our study.

Regarding the exclusion of vessels, based on visual comparison of vessels in volume space, Frangi-filter detection of vessels in volume space, and surface detection of vessels, we found no evidence to develop additional exclusion criteria (Supp. Fig. 3). On the contrary, we identified a number of false negatives in both the surface maps and volume maps. Notable exceptions to this rule seemed to occur at premotor areas F2 and F3 (Matelli et al., 1984; Patterns of cytochrome oxidase activity in the frontal agranular cortex of the macaque monkey). In these regions, we observed peculiar “pockets” of signal drop-out in equivolumetric layers 4-5. It is unclear what these signal-voids represent but it is interesting to note that these cortical areas F1-F5 were originally delineated by distinct CO+ positive large cells (Matelli et al., 1984).

(3) Attempts to obtain pial vascular structures were made (Figure 2). As mentioned in this manuscript, the blooming effect of susceptibility contrasts is problematic. In the MRI community, T1-based Gd contrast agents have been used for mapping large vasculature, which is a better approach for obtaining pial vascular structures. Alternatively, computer tomography with a blood contrast agent can be used for mapping blood vasculature noninvasively. This issue should be discussed.

We agree with the reviewer that T1-based contrast agents may offer more precise direct localization of large vessels in pial vasculature. However, the primary focus of our study was not on visualizing pial vascular structures, but rather on measuring vascular volume across cortical layers. For this purpose, we opted to use ferumoxytol, which provides superior T2*-contrast and about ten times longer plasma half-life compared to gadolinium. While we anticipated artifacts from the pial network, we developed a novel method to indirectly map these long-distance susceptibility artifacts arising from large vessels onto the cortical surface (Fig. 2A). If the goal would be to specifically visualize pial vessels, we applaud the high-resolution TOF angiography developed for direct vessel visualization (Bollman et al., 2022; https://doi.org/10.7554/eLife.71186)

Changes in text:

“4.1 Methodological considerations - vessel density informed MRI

While the pial vessels can be directly visualized using high-resolution time-of-flight MRI (Bollmann et al., 2022), and computed tomography (Starosolski et al., 2015), imaging of the dense vascularity within the large and highly convoluted primate gray matter presents other formidable challenges. Here, we used a combination of ferumoxytol contrast agent and cortical layer resolution 3D gradient-echo MRI to map cerebrovascular architecture in macaque monkeys. These methods allowed us to indirectly delineate large vessels and indirectly estimate translaminar variations in cortical microvasculature.”

(4) Since baseline R2* is related to baseline R2, vascular volume, iron content, and susceptibility gradients, it is difficult to correlate it with physiological parameters. Baseline R2* is also sensitive to imaging parameters; higher spatial resolution tends to result in lower R2* values (closer to the R2 value). Therefore, baseline R2* findings need to be emphasized.

We agree with the reviewer's comment on the complexity of correlating baseline R2* with vasculature, given its sensitivity to multiple factors such as venous oxygenation, iron content, and imaging parameters such as image resolution. While our study focuses on vascular measurements, one could also highlight iron’s role in brain energy metabolism. Deoxygenated blood affects R2*, iron in oligodendrocytes supports myelination and neuronal signaling, and iron’s role in cytochrome c oxidase during electron transport impacts mitochondrial energy production. These metabolic factors collectively affect baseline R2* and link it to vasculature. Though quantitative susceptibility mapping (QSM) could help differentiate these different factors, it is beyond the scope of this study.

(5) CBV-weighted deltaR2* is correlated with various other metrics (cytoarchitectural parcellation, myelin/receptor density, cortical thickness, CO, cell-type specificity, etc.). While testing the correlation between deltaR2* and these other metrics may be acceptable as an exploratory analysis, it is challenging for readers to discern a causal relationship between them. A critical question is whether CBV-weighted deltaR2* can provide insights into other metrics in diseased or abnormal brain states. If this is the case, then high-resolution deltaR2* will be useful. Please comment on this possibility.

We agree with the reviewer that correlation deltaR2* with other metrics, such as myelin and cortical thickness, receptors and interneuron types, remains exploratory. Establishing causal relationships requires advanced multivariate analysis across cortical layers, but mapping histological stains to cortical layers is still under development. While this exploratory approach is promising, the ability to apply these insights to diseased or abnormal brain states is not yet clear. Layer-specific analysis of vasculature and function in disease is a future goal, and ongoing work aims to expand this line of inquiry. For now, while high-resolution deltaR2* may indeed offer diagnostic potential, we prefer to refrain from overstating its clinical utility at this stage. We agree that multimodal studies integrating neuroanatomy, function, and vascular metrics will be valuable for deeper insights into brain abnormalities.

Changes in text:

“4.3 The vascular network architecture is intricately connected to the neuroanatomical organization within cerebral cortex

…To comprehensively understand the factors contributing to the vascular organization of the brain, experimental disentanglement through multivariate analysis of laminar cell types and receptor densities is needed (Hayashi et al., 2021, Froudist-Walsh et al., 2023).”

(6) There is no discussion about the deltaR2* difference across subcortical areas (Figure 1). This finding is intriguing and warrants a thorough discussion in the context of the cortical findings.

We thank the reviewer for this comment. We have expanded discussion on subcortical structures:

Section 4.3, 1st paragraph:

“In the cerebral cortex, neurons account for a significant portion (≈80-90%) of energy demand, with most of this energy allocated to signaling (≈80%) and maintaining membrane resting potentials (≈20%) (Attwell and Laughlin, 2001; Howarth et al., 2012). Since firing frequency is modulatory and the neural networks utilize distributed coding, the maintenance of resting-state membrane potential determines the minimal energy budget and the lower-limit for cerebral perfusion. Based on neuronal variability and energy dedicated to maintaining surface potential, this suggest an approximate (4 × 20% ≈) 80% variation in CBF and a resultant 25% variation in CBV across the cortex, in line with Grubbs' law (CBV = 0.80 × CBF0.38) (Grubb et al., 1974). In the cerebellar cortex, neuron density is higher, and the resting potentials are thought to account for more than 50% of energy usage (Howarth et al., 2012), aligning with its higher vascular volume compared to the cerebral cortex (Fig. 1F). However, this is a simplified estimation, and a more comprehensive assessment would need to account for consider an aggregate of biophysical factors such as…”

Section 4.3, 4th paragraph:

“When viewed in terms of information flow, CBV appear to decrease along the canonical circuit pathway (e.g., L4→L2/3→L5) in the primary visual cortex (Douglas and Martin, 2007) and as one ascends the hierarchy (e.g., V1→V2→V3&4→MT→7A) from primary sensory areas (Fig. 3F, Supp. Fig. 8) (Felleman and Van Essen et al., 1991, Markov et al., 2014). A similar pattern is observed in the auditory hierarchy, where the inferior colliculus, an early processing hub, exhibits the highest vascular volume, followed by a gradual reduction along cortical auditory ‘where’ and ‘what’ pathways (Fig. 1F, Fig. 3B).”

(7) Figure 3 is missing. Several statements in the manuscript require statistics (e.g., bimodality in Figure 2D, Figure 3F).

We apologize to the reviewer for the absence of Figure 3 in the initial submission.

As for statistical testing of bimodality, we respectfully disagree and feel that this would not add much value to the manuscript. We think a descriptive, rather than rigorous, approach is sufficient in this context.

Reviewer #2 (Public review):

Summary:

This manuscript presents a new approach for non-invasive, MRI-based measurements of cerebral blood volume (CBV). Here, the authors use ferumoxytol, a high-contrast agent, and apply specific sequences to infer CBV. The authors then move to statistically compare measured regional CBV with the known distribution of different types of neurons, markers of metabolic load, and others. While the presented methodology captures an estimated 30% of the vasculature, the authors corroborated previous findings regarding the lack of vascular compartmentalization around functional neuronal units in the primary visual cortex.

Strengths:

Non-invasive methodology geared to map vascular properties in vivo.

Implementation of a highly sensitive approach for measuring blood volume.

Ability to map vascular structural and functional vascular metrics to other types of published data.

Weaknesses:

The key issue here is the underlying assumption about the appropriate spatial sampling frequency needed to capture the architecture of the brain vasculature. Namely, ~7 penetrating vessels / mm2 as derived from Weber et al 2008 (Cer Cor). The cited work begins by characterizing the spacing of penetrating arteries and ascending veins using a vascular cast of 7 monkeys (Macaca mulatta, same as in the current paper). The ~7 penetrating vessels / mm2 are computed by dividing the total number of identified vessels by the area imaged. The problem here is that all measurements were made in a "non-volumetric" manner and only in V1. Extrapolating from here to the entire brain seems like an over-assumption, particularly given the region-dependent heterogeneity that the current paper reports.

Recommendations for the authors:

Reviewer #1 (Recommendations for the authors):

- For broader readership, it would be beneficial to provide a guide on how to interpret baseline R2* versus ΔR2*.

The text was edited as follows:

“…For quantitative assessment, R2* values were estimated from multi-echo gradient-echo images acquired both before and after the administration of ferumoxytol contrast agent (Table 1). Subsequently, the baseline R2* and ΔR2*, an indirect proxy measure of CBV (Boxerman et al., 1995), volume maps for each subject were mapped onto the twelve native equivolumetric layers (ELs) (Fig. 1C). Each vertex was then corrected for normal of the cortex relative to B0 direction (Supp. Fig. 1). Surface maps for each subject were registered onto a Mac25Rhesus average surface using cortical curvature landmarks and then averaged across the subjects (Fig. 1D, E). Around cortical midthickness, the distribution of R2*, an aggregate measure for ferritin-bound iron, myelin content and venous oxygenation levels (Langkammer et al., 2012), resembled the spatial pattern of ΔR2* vascular volume. However, across cortical layers, these measures exhibited reversed patterns: R2* increased toward the white matter surface, whereas ΔR2 decreased (Fig. 1E, G).”

- The legends in Figure 1 describe green/cyan arrows, which are not visible in the figure itself.

We thank the reviewer for noting this discrepancy. The reference to green/cyan arrows was removed from the Figure 1 legend.

- There are typos in Section 3.3: "(Figure 4A, E)" and "(cluster 3; Figure 3)" should be corrected to Figure 5.

We thank the reviewer for noting this error. The references to the Figures were corrected.

Reviewer #2 (Recommendations for the authors):

The work is elegantly presented and very easy to follow. The figures and the data presented there are compelling and well-organized. I have enjoyed reading the paper, despite my disagreement with the validity of the methodology presented.

Validation against MRA methods (high resolution needed here, Bolan et al 2006, cited also by the authors). Certainly, that work used a much higher magnetic field. This could be done through collaboration if such a magnet is not available. In my humble opinion, the current arguments provided in the paper as validation fall short in convincing future readers. Other TOF approaches might be better suited (in combination with line scanning or single plane sequences) for the 3T used in this work.

We appreciate the reviewer’s suggestion regarding time-of-flight (TOF) angiography at ultra-high magnetic fields, such as 9.4T for improved visualization of fast-flowing blood in arterial vessels, as elegantly demonstrated in Bolan et al., 2006. However, our focus was on mapping vasculature across cortical layers and TOF is not optimal for imaging slow capillary blood inflow. To enhance CNR also at capillary level, we used ferumoxytol-contrast agent to create quantitative CBV-weighted cortical layer maps (Boxerman et al., 1995).

We are open to collaborative opportunities to revisit this work using ultra-high magnetic field strengths and more detailed neuroanatomical ground-truth measures. However, the recommended line scanning or single-plane sequences, at least on first impression, seem inadequate for whole-brain coverage and cortical surface mapping.

Some of the methodology can be made more accessible to non-MRI readers. For example, a more elaborate explanation of R2* and ΔR2 could benefit future readers.

Elaborated as requested (see above reply).

A more detailed discussion of the limitations of the methodology could also be beneficial here. Explain the potential implications of under-sampling denser vascular areas (i.e. with potentially more than 7 penetrating vessels per mm2).

V1, with its highest neuronal density, likely also has the highest feeding/draining vessel density. Based on this, we hypothesized that a 0.23 mm isotropic image resolution would sufficiently capture cortical arterio-venous networks, but we did not achieve the expected detection of 7 penetrating vessels per mm2. Consequently, we refrained from quantifying vessel density in other areas, albeit we did report the total vessel count.

This under-sampling likely biases our ΔR2* estimates, skewing them toward larger vessels. To address this, we used median parcel values to avoid over-representing large vessels (the long-tail in ΔR2 parcels data distribution represents large vessels) and corrected for the cortical surface bias where blood originates from and returns to the pial network. These steps helped mitigate large vessel bias as described in the methods, results and discussion (see also our response to Reviewer #1, question #1).

To improve clarity for readers, we further clarified:

Methods:

“The effect of blood accumulation in large feeding arteries and draining veins toward in the superficial layers was estimated using linear model and regressed out from the parcellated ΔR2* maps.”

Results:

“To mitigate bias resulting from undersampling the large-caliber vessels (Fig. 2A, B), median parcel values were obtained and M132 parcellated ΔR2* profiles were then detrended across ELs in each subject and then averaged.”

Discussion:

“This methodology, however, has known limitations. First, gradient-echo imaging is more sensitized toward large pial vessels running along the cortical surface and large penetrating vessels, which could differentially bias the estimation of Δ R2* across cortical layers (Fig. 2A, 2B) (Boxermann et al., 1995; Zhao et al., 2006). Additionally, vessel orientation relative to the B0 direction introduce strong layer-specific biases in quantitative ΔR2* measurements (Supp. Fig. 1C) (Ogawa et al., 1993; Viessmann et al., 2019; Lauwers et al., 2008). To address these concerns, we conducted necessary corrections for B0-orientation, obtained parcel median values and regressed linear-trend thereby mitigating the effect of undersampling large-caliber vessels across ELs (Fig. 2C, Supp. Fig. 1).”

Please note, we are currently unable to create BALSA links to the figures due to maintenance issues at the data repository. As a result, we have opted to remove the links:

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation